RECOVERY - Tissue Purchase Order Contract Acquisitions for NCI's The Cancer Genome Atlas Program

An award was made to Sloan Kettering Institution for Cancer in response to the 4/22/10 due date under RFQ-NCI-10006-AS to provide the following: lung tissue for The Cancer Genome Atlas Program, National Cancer Institute, National Institutes of Health

DUNS: 064931884

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

An award was made to Wielkopolskie Centrum Onkologii Im Marii Sklodowkiej Curie (Greater Poland Cancer Centre) in response to the 3/2/2010 interim due date, to provide breast, stomach and colon cancer casesfor The Cancer Genome Atlas Progam, National Cancer Institute, National Institutes of Health.

DUNS: 422478896

The project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

An award has been made to Duke University in response to the March 2, 2010 interim due date, to provide breast tissue for The Cancer Genome Atlas Program, National Cancer Institute, Natinoal Institutes of Health.

DUNS: 044387793

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

An award was made to Brigham & Women's Hospital in response to the March 2, 2010 interim due date, to provide colon and rectal tissue for The Cancer Genome Atlas Program, National Cancer Institute, National Institutes of Health.

DUNS: 030811269

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting. 

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

An award was made to University of California, San Francisco in response to the 2/16/2010 interim due date, to provide breast tissue for The Cancer Genome Atlas Program, Natinoal Cancer Institute, National Institutes of Health.

DUNS: 094878337

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

A modification to the original award was made to Pittsburgh University in response to the 12/18/2009 interim due date, to provide additional breast, lung and stomach tissue for The Cancer Genome Atlast Program, National Cancer Instititute, National Instititutes of Health.

DUNS: 004514360

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

An award has been made to Henry M. Jackson Foundation in response to the 3/2/10 interim due date, to provide breast tissue for The Cancer Genome Atlas Program, National Cancer Institute, National Institutes of Health.

DUNS:  144676566

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with and employee size of 500.

An award was made to Indivumed, Inc. in response to the 12/18/2009 interim due date, to provide normal adjacent colon tissue for The Cancer Genome Atlas Program, National Cancer Institue, National Institues of Health.

DUNS: 168408347

This project if funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

Original contract number HHSN261201000009I - in order for the system to accept the same contract number across multiple awards an __had to be placed behind the original contract number HHNS261201000009I in order to post the award notice.

Original contract number HHSN261201000009I - in order for the system to accept the same contract number across multiple awards an _ had to be placed behind the original contract number HHSN261201000009I in order to post the award notice.An award was made to Pittsburgh University to provide under RFQ-NCI-10006-AS; breast ductal carcinoma and breast lobular carcinoma tissue for The Cancer Genome Atlas Program, National Cancer Institute, National Institutes of Health

DUNS:  004514360

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

Original contract number HHSN261201000003I - in order for the system to accept the same contract number across multiple awards an _ had to be placed behind the original contract number HHSN261201000003I in order to post the award notice.

An award was made to Indivumed Inc. in response to the 12/18/09 due date under RFQ-NCI-10006-AS to provide the following; colon adeno; breast ductal; breast lobular; lung adeno; and gastric carcinoma tissue for The Cancer Genome Atlas Program, National Cancer Institute, National Institutes of Health

DUNS: 168408347

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

 Original contract number HHSN261201000009I - in order for the system to accept the same contract number across multiple awards an _ had to be placed behind the original contract number HHSN261201000009I in order to post the award notice.

An award was made to North Carolina University in response to the 12/18/2009 interim due date, to provide breast and lung tissue for The Cancer Genome Atlas Program, National Cancer Institute, National Institutes of Health.

DUNS: 608195277

This project is funded by the Americal Recovery and Reinvestment Act of 2009 (ARRA) and is subject of all reporting.

This procurement was classified under the North Americal Industry Classification System Code 325413 with an employee zsize of 500.

An award was made to Sloan Kettering Institution for Cancer, in response to the 12/18/09 interim due date under RFQ-NCI-10006-AS to provide the following: breast carcinoma tissue for The Cancer Genome Atlas Program, National Cancer Institute, National Institutes of Health

DUNS:  064931884

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was calssified under the North American Industry Classification System Code 325413 with an employee size of 500.

This is a combined synopsis/solicitation for commercial items using simplified acquisition procedures and prepared in accordance with format in FAR 12.6 as supplemented with additional information included in this notice.

The full text of Request for Quotation (RFQ) RFQ-NCI-10006-AS may be accessed through the National Cancer Institute's (NCI) Office of Acquisitions homepage by using the following internet address - http://rcb.cancer.gov/rcb-internet/index.jsp. (Please click on Current Request for Proposals to access). Only electronic copies of the solicitation are available. It is the offeror's responsibility to monitor the above internet site for the solicitation and any amendments. POTENTIAL OFFERORS WILL BE RESPONSIBLE FOR DOWNLOADING THEIR OWN COPY OF THE SOLICITATION AND AMENDMENTS. No collect calls will be accepted.

This project is funded thorough the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to the reporting requirements of the act.

It is anticipated this solicitation will result in multiple awards.

Awards resulting from this solicitation No. RFQ-NCI-10006-AS will include all applicable provisions and clauses in effect at the time of award for commercial items using simplified procedures.

Under this RFQ, the offeror shall provide clinically annotated biospecimens to TCGA for the following cancer types: Glioblastoma multiforme, Lung squamous cell carcinoma, Breast ductal carcinoma, Colon adenocarcinoma, Breast lobular carcinoma, Lung Adenocarcinoma , Stomach adenocarcinoma, and Other Cancer Types Currently Not Identified.

The NCI is expanding its basic and translational research programs that rely heavily on sufficient availability of high quality well annotated biospecimens suitable for use in genomic studies. The NCI's overarching goal with such programs is to improve the ability to diagnose, treat, and prevent cancer. The Cancer Genome Atlas (TCGA), one such program, is a comprehensive and coordinated effort to accelerate our understanding of the molecular basis of cancer through the application of genome analysis technologies. The NCI and the National Human Genome Research Institute (NHGRI) launched TCGA as a 3-year pilot project in 2006, and have since (August 2009) initiated the second phase of the project to study at least 20 additional cancers over 5 years. This project aims to systematically explore the entire spectrum of genomic changes involved in human cancer. Specifically, the project is designed to comprehensively analyze DNA copy number changes, including large (on the order of chromosome segments) and small (1,000-100,000 kb) scale rearrangements, transcription profiles, epigenetic modifications, sequence variation, and sequence in both tumor tissue and case-matched germline DNA. The suite of analysis platforms will be applied to a common set of molecular analytes obtained from clinically annotated high-quality tumor biospecimens and case-matched normal tissue (control). More detailed information can be found at the project's website: http://cancergenome.nih.gov. To successfully generate comprehensive data in phase two, TCGA will need in excess of 40,000 biospecimens over course of the project.